GHK-Cu

GHK-Cu is a 7.0–7.5/10 fit for skin beauty, wound healing, recovery repair, especially for readers who can match the protocol to topical route, copper sensitivity, wound status, and sterile sourcing. The best evidence anchors are Mulder et al. 1994, which Multicenter randomized evaluator-blinded diabetic ulcer trial; 98.5% median area closure versus 60.8% vehicle; lower ulcer infection incidence, and Pickart et al. 2015, which Review of GHK skin regeneration, collagen, glycosaminoglycans, immune-cell attraction, and gene-expression pathways. GHK-Cu is a human copper-binding tripeptide with the best evidence for topical skin repair and wound healing, including Mulder 1994 diabetic ulcer data showing 98.5% median closure versus 60.8% vehicle.

✅ Best for: Adults 40+ with photoaged, thinning, or collagen-depleted skin who want a low-friction topical repair signal; people recovering from microneedling, laser, chemical peels, or irritation-prone cosmetic procedures with clinician-cleared products; early androgenic thinning users who want an adjunct to minoxidil, microneedling, or red light therapy; chronic or diabetic wound contexts only under medical supervision, especially given Mulder 1994; and peptide-community users who understand that systemic injection is experimental, source carefully, and do not confuse gene-expression evidence with proven longevity outcomes.

❌ Avoid if: You have Wilson's disease, known copper overload, unexplained high copper markers, active malignancy without clinician clearance, pregnancy, or lactation. Avoid topical GHK-Cu over suspicious skin lesions or known cutaneous malignancy. Avoid injectable GHK-Cu if you cannot verify sterility, endotoxin, peptide identity, and copper content through independent testing. Athletes should check GlobalDRO or their anti-doping authority because WADA S0 can create uncertainty for non-approved systemic substances. Also avoid if you expect caffeine-like felt effects or want proven systemic longevity, cognition, or stem-cell activation.